Article

<span class="word">Chimeric <span class="word"><span class="changedDisabled">Anti-<span class="word">Glypican <span class="word">1 <span class="word"><span class="changedDisabled">Antibodies <span class="word"><span class="changedDisabled">Exert <span class="word"><span class="changedDisabled">Antitumor <span class="word"><span class="changedDisabled">Activities <span class="word">in <span class="word"><span class="changedDisabled">Xenograft <span class="word"><span class="changedDisabled">Models <span class="word">of <span class="word"><span class="changedDisabled">Lung <span class="word">and <span class="word"><span class="changedDisabled">Pancreatic <span class="word"><span class="changedDisabled">Cancers

2026-02-13

Abstract excerpt

Glypican-1 (GPC1) has emerged as a critical mediator of malignant tumor progression. GPC1 plays essential roles in regulating various signaling pathways involved in tumor cell proliferation, invasiveness, and tumorigenesis. Overexpression of GPC1 in tumors mediates oncogenic transformation, epithelial-to-mesenchymal transition, metastatic dissemination, and therapeutic resistance. Accordingly, GPC1-targeted therap...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d75f8432-b6e6-548d-94c0-97a0f19c5f8f
DOI: 10.20944/preprints202602.1130.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Research trail

Click a neighbor to travelStep 1 · 12 closest

<span class="word">Chimeric <span class="word"><span class="changedDisabled">Anti-<span class="word">Glypican <span class="word">1 <span class="word"><span class="changedDisabled">Antibodies <span class="word"><span class="changedDisabled">Exert <span class="word"><span class="changedDisabled">Antitumor <span class="word"><span class="changedDisabled">Activities <span class="word">in <span class="word"><span class="changedDisabled">Xenograft <span class="word"><span class="changedDisabled">Mode…DOI 10.20944/preprints202602.1130.v1Read

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-CancerSemantic proximity Read

G<sub>4</sub>Mab-9: An Anti-Glypican-4 Monoclonal Antibody for Multiple ApplicationsSemantic proximity Read

An Anti-Glypican-2 Monoclonal Antibody, G<sub>2</sub>Mab-7, for Flow Cytometry, Western Blotting, and ImmunohistochemistrySemantic proximity Read

Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaSemantic proximity Read

Mechanism of GLG1 driving malignant progression of hepatocellular carcinoma and development of targeted compound YHB-5Semantic proximity Read

Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver CarcinogenesisSemantic proximity Read

The cell surface glycoprotein CDCP1 in cancer—Insights, opportunities, and challengesSemantic proximity Read

Functional targeting of Glypican-4 by a conformation-specific single-domain antibodySemantic proximity Read

Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C<sub>44</sub>Mab-94 against Gastric CarcinomasSemantic proximity Read

GPC2 provides prognostic value in pan-pediatric cancers and is associated with MYCN amplification in neuroblastoma：Bioinformatics Analysis and ValidationSemantic proximity Read

Enhanced Expression of Human Cyclin G1 (CCNG1) in Tumors, a Novel Biomarker in Development for Cancer Therapy/Gene TherapySemantic proximity Read

Non-Clinical Evaluation of the Anti-PD-1 Antibody UDIZ-007Semantic proximity Read